Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

The presence of minimal residual disease (MRD) is widely recognized as a powerful predictor of therapeutic outcome in acute myeloid leukemia (AML), but methods of measurement and quantification of MRD in AML are not yet standardized in clinical practice. There is an urgent, unmet need for robust and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Mol Diagn
Hoofdauteurs: Mencia-Trinchant, Nuria, Hu, Yang, Alas, Maria Antonina, Ali, Fatima, Wouters, Bas J., Lee, Sangmin, Ritchie, Ellen K., Desai, Pinkal, Guzman, Monica L., Roboz, Gail J., Hassane, Duane C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Investigative Pathology 2017
Onderwerpen:
Regular Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500824/
https://ncbi.nlm.nih.gov/pubmed/28525762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.03.005
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items